Budget Battles
-
Johnson Rejects a Plan to Save His Speakership
-
Johnson Defies Hardliners, Pushes Ahead With Foreign Aid Plan
-
Facing Right-Wing Revolt, Johnson Says He Won't Resign
-
Johnson Unveils Plan for Israel, Ukraine Aid
-
Trump Throws Johnson a Lifeline: ‘He’s Doing a Very Good Job’
-
Biden’s New Student Debt Relief Plan Would Cost $84 Billion: Analysis
-
House Conservatives Deal a New Blow to Johnson
-
Nearly 1 in 4 of Those Removed From Medicaid Now Uninsured
By Michael RaineyMillions of Americans have been removed from state-level Medicaid programs over the last year, following the official end of the Covid-19 pandemic and the return to pre-pandemic rules governing...
-
Biden Touts Healthcare Progress With Support From a Former Rival
President Joe Biden and Sen. Bernie Sanders joined forced on Wednesday to promote the administration’s efforts to lower healthcare costs and prescription drug prices, an issue that the White House...
-
Study Raises Questions About Ozempic Cost as Medicare Spending Soars
Some widely used diabetes and weight loss drugs could be profitably manufactured for far less than they currently cost, according to a new study. The analysis, published in JAMA Network Open by...
-
Drugmakers Push Back Against Price Negotiations
By Michael RaineyMajor pharmaceutical firms are fighting a new federal program that empowers the government to negotiate lower prices for drugs that are widely prescribed in the Medicare system. The Washington Post’s...
-
Biden Proposes a $7.3 Trillion Budget for 2025
President Biden on Monday proposed a $7.3 trillion budget for fiscal year 2025 that seeks to lower the costs of prescription drugs, child care and housing while also cutting the deficit by $3...
-
UnitedHealth Faces New Justice Department Antitrust Probe: Reports
The Justice Department has reportedly launched an antitrust investigation into UnitedHealth, the nation’s largest health insurer and a top manager of pharmacy benefits and physician groups...
-
Americans’ Top Financial Worry: Healthcare
By Michael RaineyHealthcare issues claim the top spots in the list of things U.S. voters are “very” or “somewhat worried” about being able to afford, according to the latest tracking poll from the healthcare...
-
New Record for Obamacare Signups
By Michael RaineyA record 20 million people have signed up for health care through the marketplaces created by the Affordable Care Act, the Centers for Medicare and Medicaid Services announced Wednesday. This marks...
-
As Drug Prices Rise, $35 Cap on Insulin Takes Effect
By Michael RaineyPharmaceutical companies rang in the New Year as they usually do: raising prices on hundreds of medications. According to research cited by Reuters , companies like Pfizer, Sanofi and Takeda will...
-
More Than Half of Children Losing Medicaid Coverage Live in Just 5 States
By Michael RaineyAs individual states continue to disenroll millions of people from Medicaid and the Children’s Health Insurance Program (CHIP) now that pandemic-era suspension of participation guidelines has come to...
-
Biden Signs Sweeping Executive Order to Promote Competition, Lower Prices
President Joe Biden on Friday signed a sweeping executive order that aims to foster competition and limit or reverse corporate consolidation, steps that the president says will lower prices, increase...
-
FDA Sharply Narrows Recommended Use of Biogen's New Alzheimer’s Drug
The Food and Drug Administration on Thursday dramatically narrowed its recommended usage guidelines for Alzheimer’s drug Aduhelm, suggesting that only patients with milder forms of the disease should...
-
Medicare Could Save Billions on Generic Drugs by Being More Like Costco: Report
Medicare could have saved billions of dollars on generic drugs in recent years if it used a streamlined distribution system like retail giant Costco, according to an analysis published Tuesday in the...
-
House Panels Launch Investigation Into Alzheimer’s Drug Pricing and Approval
Two House committees announced Friday that they are launching an investigation into the controversial approval and pricing of Biogen’s new $56,000-a-year Alzheimer’s drug. “We have serious concerns...
-
Charts of the Day: The ‘Crazy’ Cost of the New Alzheimer’s Drug
The projected costs to Medicare from the newly approved Alzheimer’s drug Aduhelm (aducanumab) are astronomical . “Plenty of other drugs cost more than Aduhelm, which is made by Biogen and will be...